DEUTSCHE BANK AG\ - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2018$1,168,000
+6.9%
986,000
-0.7%
0.00%
-100.0%
Q1 2018$1,093,000
-66.3%
993,000
-63.3%
0.00%
-50.0%
Q3 2017$3,242,000
+209.1%
2,709,000
+207.1%
0.00%
+100.0%
Q2 2017$1,049,000
-79.7%
882,000
-79.8%
0.00%
-75.0%
Q1 2017$5,161,000
+154.1%
4,372,000
+152.1%
0.00%
+100.0%
Q4 2016$2,031,000
-63.4%
1,734,000
-61.0%
0.00%
-50.0%
Q3 2016$5,547,000
+1359.7%
4,450,000
+1252.6%
0.00%
Q2 2016$380,000
-86.6%
329,000
-86.2%
0.00%
-100.0%
Q1 2016$2,833,000
+2148.4%
2,390,000
+2415.8%
0.00%
Q4 2015$126,000
-96.5%
95,000
-96.5%
0.00%
-100.0%
Q3 2015$3,607,000
+2273.0%
2,685,000
+2696.9%
0.00%
Q2 2015$152,000
+11.8%
96,000
+6.7%
0.00%
Q1 2015$136,000
+23.6%
90,0000.0%0.00%
Q4 2014$110,000
-16.0%
90,000
-25.0%
0.00%
Q3 2014$131,000
-68.1%
120,000
-69.3%
0.00%
Q2 2014$411,000
+85.1%
391,000
+95.5%
0.00%
Q1 2014$222,000
+29.8%
200,000
+23.5%
0.00%
Q4 2013$171,000162,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2016
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,000,000$5,003,0002.71%
Weiss Asset Management LP 65,841,000$64,360,0002.62%
Davide Leone & Partners Investment Co Ltd. 10,500,000$10,513,0001.19%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,597,000$29,800,0001.14%
GLAZER CAPITAL, LLC 7,483,000$7,474,0000.36%
BLUEFIN CAPITAL MANAGEMENT, LLC 52,500$5,243,0000.33%
OAKTREE CAPITAL MANAGEMENT LP 13,428,000$13,444,0000.29%
CSS LLC/IL 5,500,000$5,498,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 40,182,000$40,159,0000.23%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,606,000$2,606,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders